Instem PLC on Monday reported growth in profit and revenue last year, and said its in silico portfolio will be a significant area of planned investment as it seeks to take advantage of industry. | May 15, 2023
Instem PLC on Thursday said it agreed a new five-year contract with the US government s National Toxicology Programme, further expanding its use of Instem s preclinical software and allowing access to. | May 11, 2023